- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02295592
TSTstarr + for Treatment of Severe Prolapsed Hemorrhoids --- a Multi-center Randomized Controlled Clinical Trail
November 19, 2014 updated by: Sixth Affiliated Hospital, Sun Yat-sen University
TSTstarr+ in the treatment of severe hemorrhoids prolapse--A multi center randomized controlled clinical trial.The aim of this stuy is to compare the first year hemorrhoids recurrence rate of TSTstarr+ and PPH in the treatment of severe hemorrhoids.
Study Overview
Study Type
Interventional
Enrollment (Anticipated)
780
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Lin Hongcheng, Medicine Doctor
- Phone Number: +86 159158157 76
- Email: linhongcheng@hotmail.com
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 65 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- severe prolapsed hemorrhoids
- no significant anal-malformation before operation
- having signed the informed consent.
Exclusion Criteria:
- needing emergency operation or having previous history of hemorrhoids operation
- with other anal diseases at the same time such as : anal fissure, anal fistula and perianal abscess and so on
- diagnosed with inflammatory bowel disease or proctitis
- diagnosed with colorectal cancer
- associated with cardiovascular and cerebrovascular diseases and other diseases so that can not tolerate surgery or increase the risk of surgery
- with chronic or acute renal insufficiency patients
- coagulation abnormalities or with anticoagulation treatment at present
- diagnosed with diabetes with poor glycemic control
- in women with pregnant or menstruation
- The intellectual disabilities or mental disorder
- had participated in other clinical trial before we selected 4 weeks
- other severe complications.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: group A( TSTstarr+ group)
TSTstarr+ is a kind of modified STARR(stapled transanal rectal resection ) operation, compared to the traditional STARR operation, it does not need two staplers but with a larger diameter stapler, " +" means better .
Patients in group A with severe prolapsed hemorrhoids will undergo TSTstarr+ operation .
|
TSTstarr+ : a kind of modified STARR(stapled transanal rectal resection ) operation, compared to the traditional STARR operation, it does not need two staplers but with a larger diameter stapler, " +" means better .
Patients in group A with severe prolapsed hemorrhoids will undergo TSTstarr+ operation .
|
ACTIVE_COMPARATOR: group B ( PPH group)
PPH is short fo procedure for prolapsed hemorrhoids .Patients in group B with severe prolapsed hemorrhoids will undergo PPH operation.
|
PPH is short fo procedure for prolapsed hemorrhoids .Patients in group B with severe prolapsed hemorrhoids will undergo PPH operation.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
the recurrence rate of the severe prolapsed Hemorrhoids after surgery
Time Frame: 2 years
|
780 patients will be enrolled in one year.All patients will be followed up for one year, and then calculate 1 year recurrence rate between TSTstarr+ group and PPH group
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Operation time
Time Frame: 1 year
|
1 year
|
Intraoperative hemorrhage
Time Frame: 1 year
|
1 year
|
The weight of specimens
Time Frame: 1year
|
1year
|
The volume of specimens
Time Frame: 1year
|
1year
|
The number of patients with anal pain after surgery
Time Frame: 2 years
|
2 years
|
The number of patients with fecal urgency after surgery
Time Frame: 2 years
|
2 years
|
The number of patients with stricture of anus after surgery
Time Frame: 2 years
|
2 years
|
The number of patients with hemorrhage after surgery
Time Frame: 2 years
|
2 years
|
The number of patients with retention of urine in the early time after surgery
Time Frame: 2 years
|
2 years
|
The number of patients with edema of the anal margin in the early time after surgery
Time Frame: 2 years
|
2 years
|
The time of returning to normal
Time Frame: 2 years
|
2 years
|
The total cost of hospitalization
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
November 1, 2014
Primary Completion (ANTICIPATED)
April 1, 2016
Study Completion (ANTICIPATED)
October 1, 2016
Study Registration Dates
First Submitted
November 5, 2014
First Submitted That Met QC Criteria
November 19, 2014
First Posted (ESTIMATE)
November 20, 2014
Study Record Updates
Last Update Posted (ESTIMATE)
November 20, 2014
Last Update Submitted That Met QC Criteria
November 19, 2014
Last Verified
October 1, 2014
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2014ZSLYEC-021
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hemorrhoids
-
Vilnius UniversityBiolitec Pharma Ltd.UnknownHemorrhoids Second Degree | Hemorrhoids Third DegreeLithuania
-
Ventrus Biosciences, IncTerminatedInternal HemorrhoidsUnited States
-
Societa Italiana di Chirurgia ColoRettaleSICCR - Gaetano GalloCompletedSecond-degree HemorrhoidsItaly
-
Medtronic - MITGCompletedHemorrhoids, InternalUnited States
-
The Second Affiliated Hospital of Hunan University...Hunan University of Traditional Chinese Medicine; Zhengfeng Medical Technology...Unknown
-
Universitätsklinikum Hamburg-EppendorfCompletedInternal Hemorrhoids
-
BayerCompletedAcute HemorrhoidsRussian Federation
-
Nivagen Pharmaceuticals Inc.CompletedInternal HemorrhoidsUnited States, India
-
Universidade do PortoCompletedHemorrhoids, InternalPortugal
-
G & W Laboratories Inc.CompletedInternal HemorrhoidsUnited States